Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Michael W Depasquale is Chief Executive Officer at Bio Key International. OQRO lists 7 transactions filed with the SEC under this name, the latest on Jul 3, 2026, each linked to the official Form 4.
Chief Executive Officer
Disclosures on record
7
Companies involved
1
Bio Key InternationalBKYI
7 disclosures · Jun 2025 – Jul 2026 · 5 bought
Jun 30, 2026250disclosed Jul 3
DetailsOfficial recordDec 31, 20252,500disclosed Jan 6
DetailsOfficial recordSep 15, 2025Bought~$1.9Kdisclosed Sep 17
DetailsOfficial recordSep 16, 2025Bought~$1.4Kdisclosed Sep 17
DetailsOfficial recordJun 13, 2025Bought~$3.9Kdisclosed Jun 16
DetailsOfficial recordJun 3, 2025Bought~$3.3Kdisclosed Jun 4
DetailsOfficial recordJun 3, 2025Bought~$4K
DetailsOfficial recordMichael W Depasquale bought shares on the open market in 2011, 2020, 2021, 2022, 2023 and 2025.
Michael W Depasquale reported 26 open-market purchases and 0 sales since 2011; purchases in 6 different years, most recently 2025.
| Year | Bought | Sold |
|---|---|---|
| 2025 | $15K5×5 trades | — |
| 2023 | $40K5×5 trades | — |
| 2022 | $12K5×5 trades | — |
| 2021 | $38K5×5 trades | — |
| 2020 | $31K4×4 trades | — |
| 2011 | $5.8K2×2 trades | — |
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. Dollar totals use the price the filer reported; lines with no price count as trades without a value.
Michael W Depasquale reported 26 open-market purchases and 0 sales here, 2011 to 2025.
Closing prices and the companies' last annual figures; a − or + is a fact of the close, not a forecast.
As of the latest filing on , Michael W Depasquale reported holding 10,778 shares of Bio Key International (BKYI), worth about $23K at the last close of $2 (Nov 16, 2026).
Bio Key International's proxy statement reports total compensation of $347K for its chief executive for fiscal year 2025, after $309K for 2024. Michael W Depasquale files with the SEC as Chief Executive Officer of Bio Key International. The total is the one in the Summary Compensation Table: it counts stock awards at their value on the grant date, so it is not the cash received. Proxy statement filed Jul 24, 2026
| Company | Shares reported | How held | Last close | Value at last close | Reported |
|---|---|---|---|---|---|
| Bio Key International BKYI | 10,778 | 11K direct | $2 | $23K | Jun 30, 2026 |
Is this Michael W Depasquale’s net worth? No. A Form 4 reports the shares an insider owns in one company after each transaction, directly or through trusts and entities. It says nothing about cash, other investments, property or debt, options not yet exercised are not counted here, and a holding reported some time ago may have changed without a new filing. The value is shares times the last stored close, not a price anyone received. Sources: the filings listed below, each linked to EDGAR. Compare with the biggest insider stakes.
On the latest SEC Form 4, dated Jun 30, 2026, Michael W Depasquale reported holding 10,778 shares of Bio Key International (BKYI). At the last close of $2 on Nov 16, 2026, that is about $23K. This is the stake disclosed in filings, not a net worth.
Bio Key International's proxy statement reports total compensation of $347K for its chief executive for fiscal year 2025, after $309K for 2024. Michael W Depasquale files with the SEC as Chief Executive Officer of Bio Key International. The total is the one in the Summary Compensation Table: it counts stock awards at their value on the grant date, so it is not the cash received.
Michael W Depasquale bought shares on the open market in 2011, 2020, 2021, 2022, 2023 and 2025.
In SEC filings since 2011: the latest open-market purchase is from 2025; no open-market sale is on record.
Bio Key International (BKYI), from 2011 to 2025: 26 purchases and 0 sales.